05:32 PM EDT, 07/08/2024 (MT Newswires) -- Enveric Biosciences ( ENVB ) filed a registration statement on Monday with the US Securities and Exchange Commission for the potential sale of up to $200 million of its securities in one or more offerings.

The filing covers common shares, preferred shares, warrants, and units.

Net proceeds from the sale will be used for general corporate purposes, including working capital and acquisitions, according to the filing.

Price: 0.5018, Change: -0.01, Percent Change: -1.61